SI
SNDX icon

Sofinnova Investments’s Syndax Pharmaceuticals SNDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$14.3M Sell
1,524,440
-750,783
-33% -$7.03M 0.87% 30
2025
Q1
$28M Buy
2,275,223
+1,616,596
+245% +$19.9M 1.83% 13
2024
Q4
$8.71M Sell
658,627
-128,372
-16% -$1.7M 0.63% 35
2024
Q3
$15.1M Sell
786,999
-1,366,670
-63% -$26.3M 1.2% 20
2024
Q2
$44.2M Buy
2,153,669
+545,129
+34% +$11.2M 2.3% 11
2024
Q1
$38.3M Buy
1,608,540
+532,754
+50% +$12.7M 2.13% 15
2023
Q4
$23.2M Buy
1,075,786
+133,969
+14% +$2.9M 1.3% 21
2023
Q3
$13.7M Sell
941,817
-640,474
-40% -$9.3M 0.86% 28
2023
Q2
$33.1M Buy
1,582,291
+506,867
+47% +$10.6M 2.17% 14
2023
Q1
$22.7M Buy
1,075,424
+372,350
+53% +$7.86M 1.45% 19
2022
Q4
$17.9M Buy
703,074
+178,072
+34% +$4.53M 1.06% 22
2022
Q3
$12.6M Buy
525,002
+111,574
+27% +$2.68M 0.73% 24
2022
Q2
$7.95M Sell
413,428
-303,636
-42% -$5.84M 0.66% 29
2022
Q1
$12.5M Sell
717,064
-234,162
-25% -$4.07M 0.95% 24
2021
Q4
$20.8M Buy
951,226
+537,385
+130% +$11.8M 1.22% 21
2021
Q3
$7.91M Buy
+413,841
New +$7.91M 0.47% 40
2021
Q2
Sell
-298,644
Closed -$6.68M 72
2021
Q1
$6.68M Sell
298,644
-74,265
-20% -$1.66M 0.4% 41
2020
Q4
$8.29M Buy
+372,909
New +$8.29M 0.49% 38
2020
Q3
Sell
-91,964
Closed -$1.36M 80
2020
Q2
$1.36M Buy
+91,964
New +$1.36M 0.09% 57
2019
Q4
Sell
-243,150
Closed -$1.82M 65
2019
Q3
$1.82M Buy
243,150
+421
+0.2% +$3.15K 0.16% 56
2019
Q2
$2.26M Buy
242,729
+29,370
+14% +$273K 0.21% 47
2019
Q1
$1.12M Sell
213,359
-136,751
-39% -$718K 0.11% 54
2018
Q4
$1.56M Buy
350,110
+176,998
+102% +$788K 0.19% 55
2018
Q3
$1.4M Buy
173,112
+74,499
+76% +$602K 0.12% 54
2018
Q2
$693K Buy
98,613
+86,489
+713% +$608K 0.08% 54
2018
Q1
$173K Buy
+12,124
New +$173K 0.03% 47